- Home
- AMTD vs INMB Comparison
AMTD vs INMB Comparison
Compare AMTD & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMTD
- INMB
- Stock Information
- Founded
- AMTD 2003
- INMB 2015
- Country
- AMTD France
- INMB United States
- Employees
- AMTD N/A
- INMB N/A
- Industry
- AMTD
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- AMTD
- INMB Health Care
- Exchange
- AMTD Nasdaq
- INMB Nasdaq
- Market Cap
- AMTD 84.2M
- INMB 68.9M
- IPO Year
- AMTD 2019
- INMB 2019
- Fundamental
- Price
- AMTD $1.22
- INMB $2.01
- Analyst Decision
- AMTD
- INMB Buy
- Analyst Count
- AMTD 0
- INMB 4
- Target Price
- AMTD N/A
- INMB $9.53
- AVG Volume (30 Days)
- AMTD 49.7K
- INMB 772.2K
- Earning Date
- AMTD 04-30-2025
- INMB 10-30-2025
- Dividend Yield
- AMTD N/A
- INMB N/A
- EPS Growth
- AMTD N/A
- INMB N/A
- EPS
- AMTD 0.76
- INMB N/A
- Revenue
- AMTD $67,032,000.00
- INMB $50,000.00
- Revenue This Year
- AMTD N/A
- INMB $142.83
- Revenue Next Year
- AMTD N/A
- INMB $14,780.90
- P/E Ratio
- AMTD $1.59
- INMB N/A
- Revenue Growth
- AMTD N/A
- INMB N/A
- 52 Week Low
- AMTD $0.92
- INMB $1.71
- 52 Week High
- AMTD $1.79
- INMB $11.64
- Technical
- Relative Strength Index (RSI)
- AMTD 75.16
- INMB 40.89
- Support Level
- AMTD $1.02
- INMB $1.71
- Resistance Level
- AMTD $1.05
- INMB $2.00
- Average True Range (ATR)
- AMTD 0.06
- INMB 0.14
- MACD
- AMTD 0.02
- INMB 0.03
- Stochastic Oscillator
- AMTD 83.02
- INMB 44.78
About AMTD AMTD IDEA Group each representing six (6)
AMTD IDEA Group is a financial institution operating in five business segments: The capital market solutions segment assists customers in raising funds through equity and debt financing, private placements, and debt issuances. The digital solutions and other services segment provides institutional and corporate clients with paid access to enhance investor communication and relations, corporate communication also provides digital financial solution services. The Media and entertainment segment offers print and digital advertising campaigns, licensing, and marketing services including branded content, video production. The hotel operations, hospitality, and VIP services segment engages in hotel investments, hotel operations, hospitality, and VIP services; and Strategic investment segment.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.